Page last updated: 2024-08-23

substance p and Urinary Bladder Neoplasms

substance p has been researched along with Urinary Bladder Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Aldardeir, N; Baeesa, S; Bahakeem, B; Bamaga, A; Faizo, E; Fawzy Halawa, T; Hakamy, S; Hassan, A; Katib, Y; Kurdi, M; Maghrabi, Y; Mehboob, R; Moshref, R; Nasief, H; Rasool, S; Saeedi, R; Tanvir, I; Waseem, H1
Burnstock, G; Chapple, CR; Crowe, R; Light, JK; Moss, HE1
Burnstock, G; Chilton, CP; Crowe, R; Light, K1

Other Studies

3 other study(ies) available for substance p and Urinary Bladder Neoplasms

ArticleYear
Immunolocalization of neurokinin 1 receptor in WHO grade 4 astrocytomas, oral squamous cell and urothelial carcinoma.
    Folia neuropathologica, 2022, Volume: 60, Issue:2

    Topics: Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Epithelial Cells; Glioblastoma; Humans; Mouth Neoplasms; Receptors, Neurokinin-1; Substance P; Urinary Bladder Neoplasms; World Health Organization

2022
Patients with lower motor spinal cord lesion: a decrease of vasoactive intestinal polypeptide, calcitonin gene-related peptide and substance P, but not neuropeptide Y and somatostatin-immunoreactive nerves in the detrusor muscle of the bladder.
    The Journal of urology, 1991, Volume: 145, Issue:3

    Topics: Adult; Calcitonin Gene-Related Peptide; Fluorescent Antibody Technique; Humans; Male; Meningomyelocele; Neuropeptide Y; Somatostatin; Substance P; Urinary Bladder; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Vasoactive Intestinal Peptide

1991
Vasoactive intestinal polypeptide-, somatostatin- and substance P-immunoreactive nerves in the smooth and striated muscle of the intrinsic external urethral sphincter of patients with spinal cord injury.
    The Journal of urology, 1986, Volume: 136, Issue:2

    Topics: Adolescent; Adult; Aged; Fluorescent Antibody Technique; Humans; Muscle, Smooth; Muscles; Nerve Fibers; Somatostatin; Spinal Cord Injuries; Substance P; Urethra; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Vasoactive Intestinal Peptide

1986